Coenzyme-A Inc.
PPII
Other OTC0.00
USD
- -
- -
ISIN
US1920791019
CUSIP
192079101
Return %
Stock
S&P500
1Y
0.00
26.53
3Y
100.00
76.60
5Y
-99.97
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Nickoloaus D. Skouras
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 12512 Beverly Park Road Lynnwood WA United States of America 98087
- IPO Date
- Sep 8, 2009
- Website
- coenzymea.com
- Similar Companies
- Business
- Coenzyme-A Inc. (PPII) formulates and manufactures nutraceutical supplements and skin and hair care products in the United States and internationally; offers energy drinks, skin rejuvenating serums, fat management products, skin treatment solutions, fatty acid and cholesterol metabolism aids, skin rejuvenating formulas, and nutritional supplements supporting bone, joint, ligament, cartilage, and connective tissue functions; provides sports-specific formulas, women's and men's targeted products, as well as wellness, energy, and body sculpting offerings. The company, founded in 1998 and headquartered in Lynnwood, Washington, operates within the personal care products industry, targeting consumers seeking natural health solutions for nutritional deficiencies, metabolic support, and anti-aging benefits. It trades on the OTC Pink Sheets market with a minimal market capitalization of approximately US$111 and reports trailing twelve-month revenue of US$345.65k against earnings of -US$4.60m, reflecting ongoing financial challenges with no recent funding rounds, acquisitions, partnerships, or product launches disclosed in public records as of late 2025.